TITLE

Iron Supplementation for Anemia After Hip Fracture Surgery A Randomized Trial of 300 Patients

AUTHOR(S)
Parker, Martyn J.
PUB. DATE
February 2010
SOURCE
Journal of Bone & Joint Surgery, American Volume;Feb2010, Vol. 92-A Issue 2, p265
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Anemia as a consequence of surgery is often treated with iron therapy. The evidence base for this practice is limited. To determine if oral iron therapy is beneficial for the treatment of anemia after surgery for the treatment of a hip fracture, we undertook a prospective, randomized controlled trial. Methods: Three hundred patients with a hemoglobin level of <110 g/L after treatment for a hip fracture were randomized to receive either a twenty-eight-day course of ferrous sulfate therapy or no iron therapy. Hemoglobin levels were measured at six weeks after surgery. The length of the hospital stay and the mortality rate at one year were compared between groups. Results: The mean rise in hemoglobin levels six weeks after discharge from the hospital was 21 g/L in the iron group, compared with 18 g/L in the no-iron group (p = 0.07). There was no significant difference between the two groups with regard to the length of hospital stay or the mortality rate. Seventeen percent of the patients who were allocated to iron therapy reported adverse effects of the medication. Conclusions: The present study demonstrated that iron therapy had no clinically relevant benefit when used to treat anemia associated with a hip fracture.
ACCESSION #
48983897

 

Related Articles

  • Iron Supplementation for Anemia After Hip Fracture Surgery A Randomized Trial of 300 Patients. Parker, Martyn J. // Journal of Bone & Joint Surgery, American Volume;Feb2010, Vol. 92-A Issue 2, p265 

    Background: Anemia as a consequence of surgery is often treated with iron therapy. The evidence base for this practice is limited. To determine if oral iron therapy is beneficial for the treatment of anemia after surgery for the treatment of a hip fracture, we undertook a prospective, randomized...

  • Ferrous sulfate.  // Reactions Weekly;11/20/2010, Issue 1328, p21 

    The article describes the case of a man who developed pseudomelanosis ilei while receiving treatment with ferrous sulfate for iron deficiency anaemia.

  • Which is the Ideal Iron Preparation for Treating Anemia? Paul, Yash // Indian Pediatrics;Aug2008, Vol. 45 Issue 8, p705 

    The article seeks information on the ideal iron salt preparation for treating anemia. It is stated that iron deficiency anemia (IDA) is widespread in children. It notes that every manufacturer claims that its preparations are better than the others. Also requested is a brief comparative profile...

  • Ferric carboxymaltose.  // Australian Prescriber;Aug2011, Vol. 34 Issue 4, p120 

    The article offers information on the Ferinject from Vifor Pharma and its effectiveness in treating iron deficiency. The ferric carboxymaltose is available in 500 milligrams for infusion, 100 milligrams of iron, and 10 milliliters of solution. It presents the proper intravenous administration...

  • Nephrology/pediatric nephrology.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS65 

    Presents an abstract of the research manuscript `Night-time oral iron dosing in CAPD patients, hemoglobin response and tolerability,' by G.B. Pylypchuk et al. Ferrous sulfate dose.

  • Managing anemia in dialysis patients: hemoglobin cycling and overshoot. Singh, Ajay K.; Milford, Edgar; Fishbane, Steven; Keithi-Reddy, Sai Ram // Kidney International;Sep2008, Vol. 74 Issue 5, p679 

    The article presents a discussion on management of anemia in dialysis patients. It mentions that anemia is present in most of patients on dialysis and presents a combination of erythropoietin deficiency and iron deficiency, as well as bone marrow resistance to erythropoietin. The management of...

  • Evaluation of efficacy and tolerability of ferrous bisglycinate tablets in comparison with ferrous sulphate tablets in patients with iron deficiency anemia. Singh, Saroj; Singh, Shikha; Lata, Subhadra; Jain, Ratna; Bissa, Uma; Ramanidevi, T.; Taraporewala, Shirin; Vaishnavi, Meera; Bhalerao, Anuja; Kulkarni, K. R.; Pandit, R. S.; Nagabhushan, K. H.; Jain, Sadhna // Journal of Pharmacy Research;Aug2011, Vol. 4 Issue 8, p2836 

    Background: Iron deficiency anemia is the most common nutritional deficiency disorder in the world, especially in India and other developing countries. Surveys in different parts of the country reveal that 87% of pregnant women suffer from anemia and about 10% have severe anemia. Aim: The...

  • Safety and efficacy of lactoferrin versus ferrous sulphate in curing iron deficiency and iron deficiency anaemia in hereditary thrombophilia pregnant women: an interventional study. Paesano, Rosalba; Pacifici, Enrica; Benedetti, Samanta; Berlutti, Francesca; Frioni, Alessandra; Polimeni, Antonella; Valenti, Piera // BioMetals;Oct2014, Vol. 27 Issue 5, p999 

    Objective Evaluate the safety and efficacy of bovine lactoferrin (bLf) versus the ferrous sulphate standard intervention in curing iron deficiency (ID) and ID anaemia (IDA) in pregnant women affected by hereditary thrombophilia (HT). Design Interventional study. Setting Secondary-level hospital...

  • Ferrous Sulfate (Iron).  // AHFS Consumer Medication Information;Apr2017, p1 

    Ferrous sulfate provides the iron needed by the body to produce red blood cells. It is used to treat or prevent iron-deficiency anemia, a condition that occurs when the body has too few red blood cells because of pregnancy, poor diet, excess bleeding, or other medical problems.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics